Miami
US Sunbelt mayors push back against Trump’s virus optimism
US Sunbelt mayors warned Sunday that their cities are at risk of being overwhelmed by a surge of coronavirus cases as they pushed back against US President Donald Trump’s attempt to minimize the gravity of the spreading virus. COVID-19 has been raging for weeks across southern and western states. Florida has registered 10,000 new cases on some days. Arizona has seen record hospitalizations. And intensive care units in Houston, Texas are operating near maximum capacity. With President Trump continuing to play down the disease eschewing a mask, continuing to address large gatherings, saying a vaccine is only months away and asserting that “99 percent” of cases are not serious the exasperation of local officials has begun to boil over, with some floating the idea of new stay-at-home orders. “...
Flo Rida Teams With His Medical Doctor To Set Up COVID-19 Mobile Testing Site
Source: DJDM/WENN.com / WENN Once again, our culture celebrities continue to come to the aid of their communities during the COVID-19 pandemic while Trump’s administration allows America to burn to the ground. The latest rapper to take it upon himself to do what our government should be doing is Miami’s own Flo Rida as TMZ is reporting that the “My House” rapper teamed up with his personal doctor to open up a mobile coronavirus testing center to help people take tests to learn if they have the deadly virus. Investing his own cash to build the project, the $1.5 million healthcare venture dubbed The Asktabs Mobile Wellness Center has already begun to make the rounds and test Floridians as the state begins to re-open at a time when The Rona is still running rampant across the nation. From TMZ...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
